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1ABSTRACT
Intracranial pressure is an important parameter to monitor, and elevated 
intracranial pressure can be life threatening. Elevated intracranial pressure is indicative of 
distress in the brain attributed by conditions such as aneurysm, traumatic brain injury, 
brain tumor, hydrocephalus, stroke, or meningitis. 
Electrocorticography (ECoG) recordings are invaluable in understanding epilepsy 
and detecting seizure zones. However, ECoG electrodes cause a foreign body mass 
effect, swelling, and pneumocephaly, which results in elevation of intracranial pressure 
(ICP).Thus, the aim of this work is to design an intracranial pressure monitoring system 
that could augment ECoG electrodes.
A minimally invasive, low-cost epidural intracranial pressure monitoring system 
is developed for this purpose, using a commercial pressure transducer available for 
biomedical applications. The system is composed of a pressure transducer, sensing cup, 
electronics, and data acquisition system. The pressure transducer is a 
microelectromechanical system (MEMS)-based die that works on piezoresistive 
phenomenon with dielectric isolation for direct contact with fluids.
The developed system was bench tested and verified in an animal model to 
confirm the efficacy of the system for intracranial pressure monitoring. The system has a 
0.1 mmHg accuracy and a 2% error for the 0-10 mmHg range, with resolution of 0.01 
mmHg. This system serves as a minimally invasive (2 mm burr hole) epidural ICP 
2monitor, which could augment existing ECoG electrode arrays, to simultaneously 
measure intracranial pressure along with the neural signals. 
This device could also be employed with brain implants that causes elevation in 
ICP due to tissue - implant interaction often leading to edema. This research explores the 
concept and feasibility for integrating the sensing component directly on to the ECoG 
electrode array.
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CHAPTER 1
INTRODUCTION
Intracranial Pressure
Intracranial pressure (ICP), commonly referred to as brain pressure, is the 
pressure inside the skull. Monitoring of intracranial pressure has been important in both
neurosurgery and neurology for over two decades.
Head injury, brain swelling, tumors, and stroke are some of the most common 
brain related issues that leads to or are associated with increase in brain pressure. For 
example, Traumatic Brain Injury (TBI), usually referred to as a head injury, is a 
devastating medical problem that has huge socioeconomic consequence. There are about 
52,000 deaths and 275,000 hospitalizations every year due to TBI in the USA[1]. 
Currently, there are both invasive and noninvasive ICP monitoring technologies on the 
market. However, direct or fully-invasive measurement and detection of ICP remains the 
standard, especially for brain swelling or edema after an injury.
Invasive ICP monitors come with tradeoffs of having to deal with infection and 
postoperative complications. Thus we recognize there are disadvantages in fully-invasive 
system to be weighed against their excellent accuracy in determining the intracranial 
pressure. Noninvasive techniques are, of course, preferable with regard to infections and 
complications, but they haven't been used clinically to a great extent due to inaccuracies 
resulting from correlation or calibration factors involved[2,3,4]. Given the 
aforementioned tradeoffs between fully-invasive and noninvasive systems there is a need 
for a minimally-invasive, highly accurate diagnostic tool that would monitor brain 
pressure.
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There are several types of invasive ICP monitors currently available. They are 
classified based on the location of the device or sensor inside the skull, which relates to
the rate of infection and postoperative complications. The location of the sensor inside 
the skull determines the size of craniotomy (burr hole on the skull) required, which in 
turn is linked with the infection rate. Examining these monitoring configurations along 
with their benefits and complications, provide us insight into the design of an ICP 
monitor that fulfills the unmet clinical need.
Problem Statement
In examining neural technologies, we observe the enormous importance of 
monitoring to provide insight into how the brain works. One of the most important type 
of monitors examines patterns of electrical activity in the brain; this is called 
electrocorticography.
Electrocorticography (ECoG), often referred to as intracranial 
electroencephalogram (EEG), is a method of recording neural potentials through 
placement of electrodes on the surface of the brain. This is an incredibly useful tool for 
understanding the brain and providing therapies for numerous diseases. For instance, this 
procedure is specifically performed to understand the epileptic foci in brain that causes 
seizures, which can be removed by a surgery. There are two kinds of ECoG:
1) Intraoperative - electrodes are placed during a lesion removal surgery to map 
the epileptic zones before surgery and are removed after surgery
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2) Extraoperative - electrodes are placed for a short term implantation of 4-5 days 
to evaluate and map the brain activity over the area of epileptic foci and then 
removed. This is generally used to get a better understanding of the foci before 
the surgery.
Both require surgery and placement is in subdural space, with continuous 
monitoring. There are three kinds of electrodes in use - strip, grid and depth electrodes. 
Strip electrode are used for small areas, grid for a larger areas and depth for investigating 
deep brain structures such as the amygdala and the hippocampus. Any surgical procedure 
involves risks of infection and other complications. One of the major risk includes 
cerebral edema or brain swelling due to the presence of the electrode, and if the swelling 
is extreme a secondary surgery is performed to remove the electrodes.
The recent developments in understanding epilepsy have given birth to design of 
the wireless, implantable ECoG (electrocorticography) electrode system, which is used to 
monitor epileptic seizure zones in brain. Further, advancements in Brain Machine 
Interface (BMI) have also lead to wireless ECoG system design[5-8]. However, an 
important parameter often overlooked is the feedback from changes occurring during an 
implantation of such a system over time (e.g. 5 day recordings). In the case of surgery 
and implantation, some level of edema always occurs. Hence, we need a monitor to 
provide feedback on the level of edema. This strongly indicates the need for pressure 
measurement integration with the wireless ECoG development[9,10].
Looking at the currently available microtransducers, we find none of them are exactly 
suitable for our purpose, integration on the ECoG electrodes. The microtransducers 
available use various sensing technologies such as piezoresistors, fiber optics, fluid filled 
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strain gauge tip catheter, etc. All the existing clinically approved commercial devices are 
wired, having a catheter or some extension for the sensor to be placed in the brain. 
Further, dimensionally the existing systems are unsuitable for integration. Beyond, the 
commercially existing microtransducers cost $400-$600, just for the sensor and 
excluding surgical, monitoring, and surgeon fees. This has lead us to attempt to find a 
cost effective solution for an ICP monitoring device that could be integrated with ECoG 
electrodes.
Goals of this Research work:
The goal was to find a simple, cost-effective, and miniaturized pressure 
transducer that could be integrated with the developing wireless ECoG arrays. This 
indicates we need a pressure sensitive material or layer that could be embed onto the 
ECoG grid.
The specific goals of this thesis work are:
1) To find a pressure transducer material that could potentially be integrated with ECoG 
grid electrodes- determine dimensions and affordability match
2) To calibrate and evaluate the transducer to obtain a proof of concept that the system 
could potentially work well in measuring intracranial pressure.
Contribution of this thesis to solve the novel problem:
Piezoresistive technology was chosen as the focus of research considering the 
frequency characteristics of the ICP signal. Piezoresistance is a phenomenon of change in 
resistance of a material when a mechanical stress is applied. Unlike piezorelectricity, this 
16
phenomenon is an active transducing system meaning itrequires energy to convert the 
pressure changes to a resistance or voltage changes.
First, force resistive sensors (FSR) were investigated, which are usually used to 
detect high pressure. The sensing layer was modified for our application at a lower range 
of pressures, which hadn't previously been tested for these devices to our knowledge. 
Additionally, a commercial disposable blood pressure sensor was investigated to 
measure intracranial pressure. This sensor has a Micro-ElectroMechanical System 
(MEMS) die within that detects the changes in pressure. This die is available 
commercially and used in medical devices, which is helpful for furthering this research to 
integrate the die on the ECoG system and evaluating it.
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CHAPTER 2
BACKGROUND
Anatomical Locations for ICP Monitoring:
The brain is enveloped by three protective membranes, collectively called the 
meninges. From the cranium towards the brain, the layers are dura mater, arachnoid 
mater and the pia mater. Cerebral pressure monitoring could be performed at five 
anatomically different locations namely ventricles or cavities in brain where CSF is 
produced; brain parenchyma (brain mass); below arachnoid mater (subarachnoid); below 
dura (subdural) and just below skull (epidural). ICP monitors based on these locations are 
categorized into two broad sectors:
1) Intra-ventricular catheter or External ventricular drainage (EVD)
2) Micro-transducers
The picture below describes the anatomical locations for ICP monitoring, where devices 
other than intra-ventricular catheter falls under micro-transducers category.
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Figure 1. Anatomical locations for ICP Monitoring
This figure shows device placement area and the respective nomenclature.
Current and Existing Methods to Monitor ICP:
Intracranial pressure monitors are classified into invasive and non-invasive 
monitors. The invasive ICP devices are divided further as discussed above. In addition to 
these, ICP can be monitored invasively through a lumbar puncture technique by a spinal 
tap[11,12,13].
Invasive Intracranial Pressure Monitoring devices:
1) External Ventricular Drainage (EVD):
Intra-ventricular catheterization is considered the "gold standard" method for
monitoring ICP. This is due to the precision and accuracy the measurement carries based 
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on the placement of the sensing area at the origin of CSF production. EVD has two main 
advantages over the other methods, which has high clinical significance:
i. Provides a way to drain the CSF to control elevated pressures
ii. Administer antibiotics for ventriculities or other infections that results 
from the EVD placement itself[14-18].
In this technique a catheter is placed on the lateral ventricle of the brain through a 
right frontal burr hole procedure. Usually, a coronal drill at Kocher's point is performed 
to position the tip of the catheter in the 3rd ventricle. Alternatively, other burr holes at 
Keen's point (posterior-parietal), Frazier's point (occipital-parietal) and Dandy's point 
(occipital) are also used to reach various ventricles as desired by the surgeon based on the 
clinical relevance[2].
The technology behind EVD to measure is either saline manometer or a pressure 
transducer, which is in contact with the drained CSF through a three way stop 
valve[3].The auditory meatus serves as an external reference for the transducer to be 
closely positioned to the center of the head or the foramen of Monro. Unfortunately, 
every time the head position is changed the transducers need repositioning.
Potential complications of this system include progressive edema due to infection or 
bacterial colonization that results in the ventricular system and compression or even
blockage of the catheter drainage [2]. Further, EVDs are known for associated 
postoperative hemorrhages. On an average, 41% of the cases had post-traumatic 
hemorrhage in a study with 188 patients who underwent EVD catheterization, out of 
which 10.6 % are clinically significant or relevant having a neurological 
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deficit[19].Additionally, catheterization and placement for younger patients is still a 
problem due to a very slender ventricular system[2].
Bacterial or other infections due to EVDs range from 0-27% of the cases. If EVD 
treatment is used for longer than five days, the infection rate is further increased with 
other associated problems such as cranial fracture with CSF leakage, resulting in non-
sterile EVD[20 - 23]. Infection rates are also increased by improper placement of the 
catheter resulting in damage to the parenchyma, penetrating the ventricles and other 
cerebral structures. In a patient population of 138 about 12.3% had misplaced catheters 
and higher infection rates[24]. It is recommended practice to use a "Ghajar guide" to 
correctly position the catheter rather than by hand, but according to a survey only 3% 
American neurosurgeons use this guide on a regular basis[25, 26]. Ventricular catheter 
misplacement rate is 6.3% which results in blockage of brain matter or blood clots[27, 
28].This system is still very much in use in the clinical settings due to its ability to 
provide CSF drain to relieve pressure when intracranial hypertension is attributed by an 
abnormal mass[2].
2) Micro-transducers
Micro-transducer classifications are based on the technology used in the system to 
quantify the pressure. The various microtransducers in use are:
i. Fiber optic sensor          - Camino
ii. Piezoresistive sensors - Codman, Raumedic and Pressio
iii. Pneumatic sensors                  - Spiegelberg
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(i) The Camino ICP monitor is based on fiber optics principles, where the sensor 
transmits light via a fiber optic cable towards a displaceable mirror in contact with the 
brain tissues. The changes in the ICP are tracked through the difference in intensities 
between incident and reflected light. The sensor is usually placed in the intraparenchymal 
cells on the right frontal region about 2 cm deep. Placement over the brain parenchyma 
could be modified based on the pressure gradient suspected. Camino has different models 
for ventricular, parenchymal, subdural and epidural measurements[64]
Camino also has epidural ICP sensor models, but it does not provide the desired 
accuracy for regular clinical use. This is due to overestimation of ICP with a mean of 9 
mmHg, extending up to 30 mmHg[29]. Despite large differencesin mean ICP values 
depending on placement, ICP waveform characteristics (pulse amplitude and wave time) 
still seemed comparable irrespective of the positions[30]. Studies show that above 20 
mmHg, ICP measured epidurally is consistent with subdural measures[31]. Another study 
found out that subdural ICP recordings have excellent correlation with the ICP obtained 
from the lumbar puncture technique, proving that locations other than the ventricles or 
brain parenchyma can be used for ICP measurement[32]. This study also conclude that
difference in epidural measures compare to other locations arise from the significant 
physiological pressure difference in compartments and not due to the monitoring systems 
themselves.
In a clinical study with a population of 1000 patients, 574 probes were 
investigated and 8.5% showed positive bacterial growth, 2.5% had incidences of 
hemorrhage (4 parenchymal and 2 epidural) and technical errors occurred in 4.5% of the 
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cases[33]. In another study with 328 patients, 1.1% cases had hemorrhage, 4.75% had 
infection and 3.14% cases were reported with technical errors or faulty sensors[34].
Figure 2. Construction of Camino sensor, adapted from Camino website [64]
(ii) Codman MicroSensor uses a microchip at the tip of the nylon tube that transduce the 
ICP changes in terms of resistance values that are reflected as voltage changes. Codman 
makes sensors for ventricular, parenchymal and subdural measurements[65]. Most of 
these are used for intraparenchymal placement with a 4mm burr hole and screw[3]. These 
sensors are considered almost as accurate as ventricular ICP measurements with very low 
infection and hemorrhages rates[35, 3]. Particularly when ventricles are inaccessible due 
to compression, Codman sensors are highly preferred[3]. In a clinical study of 1000 
patients only 3 were found to have postoperative hemorrhages and no infection related to 
placement of the sensors were detected [36].
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Figure 3. Construction of Codman sensor, adapted from Codman website [65]
Raumedic Neurovent-P sensor works on the same principle of resistance changes 
to monitor ICP. A study of 99 patients shows that Neurovent sensors have no or very low 
infection rates with only 2 cases of hemorrhage that required no intervention[37].
The Pressio ICP monitor also uses piezoresistive technology to measure ICP 
changes. This sensor has undergone vast bench and laboratory testing but hasn't been 
tested in vivo thoroughly yet. Studies by Lescot et al, demonstrated ICP measurements of 
15 Pressio sensors in comparison with Codman sensors indicated a mean difference of ±7 
mmHg between the recordings from two sensors [38]. We emphasized here that no 
complications such as infection or postoperative hemorrhage were evaluated or recorded. 
In laboratory evaluation of Pressio sensor the drift was less than 0.05 mmHg with 
accuracy 0.5 mmHg over 0-100 mmHg range of measure. Pulse waveform accuracy of 
Pressio sensor was 0.2 mmHg which is better than the Codman transducer in 0-20 mmHg 
range[39]
(iii) The Spiegelberg sensor uses direct pneumatic changes to monitor ICP. This system 
has a small balloon at the distal end of a catheter to register the pressure changes and 
along with pressure this sensor can measure intracranial compliance. The Spiegelberg 
sensor has different models for ventricular, parenchymal and epidural measurement[66]. 
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Lang et al[40] has tested this sensor in 87 patients and found no significant hemorrhage 
or clinical signs of meningitis, but 3 patients had faulty measurements due to a leaking 
issue with the sensor tip. When tested for continuous intracranial compliance (cICC) 
measures by Kiening et al[41], it seemed to have poor data quality, poor prediction with 
respect to ICP and correlation to cerebral hypoxia. However, later studies with respect to 
this sensor showed that these results in TBI might be due to age related decrease in 
compliance that shadowed the results[42].
Figure 4. Spiegelberg ICP Sensor,adapted from Spiegelberg website 
[66]
Of all the micro-transducers discussed here, Neurovent-P, Spiegelberg and 
Codman are MRI compatible without any danger to the patient, while Camino and 
Pressio sensors contain ferromagnetic substances that prevent the use of these devices in
an MRI environment[43, 44].
Comparing the gold standard ventricular catheterization with micro-transducers, 
we find that EVD still stands first despite the complication involved as a result of its uses. 
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The above studies conclude that micro-transducers are as accurate as with ventricular 
catheterization[22, 40] but possess a common disadvantage or major drawback of re-
calibration and drift over time. In summary micro-transducers disadvantages include:
1) requirment of re-calibration in vivo
2) localized pressure measurement without reflecting global pressure
3) no mechanism for CSF drainage to relieve pressure, if high
4) Zero drift over long term measurements
However, the Spiegelberg sensor has ability to self-calibrate every hour, which 
sets it apart from other micro-transducers. EVD has an edge over micro-transducers due 
to resetting the transducer to atmospheric pressure and leveling it to the reference/Monro 
point at any time. Nevertheless, EVD does come with a major drawback of incorrect set 
up problems beyond the complications due to catheter itself. In EVD, the drip chamber
where CSF is drained should be in proximity with the CSF space as CSF drainage 
depends on the pressure gradient inside the cavity and on the resistance of the drainage, 
which is set by the relative height of drip chamber. Another major constraint is the three-
way valve should be close to drainage to measure the true ICP, if not chances of 
measuring the drainage pressure is relatively high. This gives rise to false pressure 
gradients and insufficient CSF drainage that may interfere with the measurement.
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Noninvasive ICP Monitoring:
It is incredibly compelling to find an alternative to the traditional invasive 
procedures, especially when accounting for the associated complications and the 
expertise of surgeons required. With the noninvasive methods complication such as 
hemorrhages and infections are greatly reduced creating a demand for improvement in 
the existing noninvasive ICP technologies. There are several popular techniques used as 
explained below.
1) Transcranial Doppler Ultrasonography (TCD)
This system uses ultrasound to monitor the changes in ICP. Ultrasound is applied 
to the middle cerebral artery to monitor blood flow velocity that serves as a predictive 
factor to estimate ICP. The difference between systolic and diastolic flow velocity is used 
to estimate the pulsatile index (PI), which seems to correlate with ICP[45,46,47].
Studies on the correlation between PI and ICP show a correlation factor of 0.439 
to 0.938 with a mean deviation of ± 4.2 mmHg compared to invasive measures below 30 
mmHg. Deviation seems to increase for higher ICP values and higher correlation boils 
down to greater individual variation, which is unacceptable for clinical use[2].
On a study by Behrens et al.[48] artificially increased ICP by lumbar infusion, 
ICP predicted from PI recording were compared with the recording of the Codman 
sensor. The results showed a 95% confidence interval from -3.8 to 43.8 mmHg for an ICP 
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of 20 mmHg determined using PI. However, Brandi et al.[49] found that PI calculated 
through ICP is too uncertain, and the best correlation had a mean difference of -3.2 ±12.6 
mmHg. Additionally, this technique demands certain level of training and expertise 
leading to inter and intra observer variations. Also, this technique has a significant 
disadvantage, since ultrasound is unable to penetrate in certain patients' skulls which 
translates to 10-15% disuse[2].
2) Tympanic Membrane Displacement (TMD)
TMD uses the technique of stapedius reflex to estimate the ICP through tympanic
membrane movement[50]. CSF and perilymph communicate via a common 
perilymphatic duct that enables in this estimation. Cochlear fluid pressure has an effect 
on the movement and positioning. When this system was tested on 148 patients, there 
was low rate of success that was attributed to increased stiffness of the perilymphatic duct 
related to aging[51]. Beyond these issues, inter-subject variability was so high in 
determining ICP through this method it was prohibited fromclinical use.
3) Optic Nerve Sheath Diameter Estimation (ONSD)
Optic nerve shares a part of central nervous system through dural sheath 
connection. The nerve sheath and white matter have a subarachnoid space in between that 
changes in diameter in case of ICP elevation. This helps in monitoring using transocular 
ultrasound. The method has a huge advantage compared to other systems due to minimal 
time (5 minutes) to estimate ICP, and it is inexpensive. This method has been evaluated 
and has showed great correlation in estimating ICP, however those studies have excluded 
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glaucoma and cataract subjects. Research on this technique shows that this method could 
be good screening test for detecting elevated ICP where invasive ICP monitor or expert 
neurosurgeons aren't available[52-54].
4) Magnetic Resonance Imaging (MRI) and Computer Tomography (CT)
MRI uses arterial, venous and CSF flow during a cardiac cycle to estimate the 
CSF velocity and ICP. This method was found to correlate well with invasively measured 
ICP withR2 = 0.965 and P<0.005. However, even this method has significant intra-
subject variation and hence cannot be used for clinical evaluation[55]. CT on the other 
hand showed no correlation with ICP in various studies[2].
ICP monitoring methods and principle are diverse as described above; additional 
methods exists such near infrared cerebral spectroscopy and fundoscopy, all of the 
methods have significant drawbacks preventing widespread use. Various considerations 
such as precision, placement of the sensor and complications, etc. must be taken into 
account when evaluating a method to monitor ICP. Microtransducers accuracy 
approaches true ICP second to EVD monitoring, if calibration and drifting issues can be 
resolved. We have established EVD comes with high risk of severe complications. 
However, it is important to acknowledge the American Brain Trauma Foundation still 
prefers the EVD for ICP monitoring as their gold standard. Noninvasive techniques have 
their own shortcoming mainly involving inaccurate measures. For example the accuracy 
in TCD is 10-15%, TMD is 60% and in ONSD is 10% [2].
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Regarding device cost, EVDs are priced about $200, while microtransducers are 
expensive ranging from $400 to $600 just for the material or sensors[16,22]. 
Additionally, the cost of maintenance, refilling, surgical procedure to accurately place 
and position the sensor and the surgeon costs should be considered. 
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CHAPTER 3
THEORY
Intracranial Pressure - An Overview
Elevation of ICP also known as intracranial hypertension is elevation of the 
pressure in the cranium. Pressure falling in range of 15-20 mmHg indicates an elevated 
ICP; 20–25 mmHg being abnormal and aggressive treatment starts at pressures over 
25mmHg. Loss of consciousness accompanies pressures exceeding 40 mmHg denoting a 
high risk state while beyond 50 mmHg, results in brain death. Thus, elevated ICP is a 
dangerous condition and requires immediate medical attention, monitoring, and 
treatment[3].
Pathophysiology: Intracranial pressure was first described by a Scottish anatomist 
Alexander Monro, from whom the Monro-Kellie hypothesis of pressure volume 
relationship originated. Per Monro’s hypothesis;abrain encased in a rigid structure is 
incompressible, so the volume of the cranial cavity must therefore be constant. The 
cranial volumes is made up of brain tissue, blood and CSF, and there exists a reciprocal 
relationship between these, such that increase in one component causes a decrease in the 
other component(s), i.e. the Monro-Kellie hypothesis[2]. Thus, an increase in any one of 
the three components will tend to increase the intracranial pressure. Minimal expansion 
of brain volume does not immediately increase ICP, but once the ICP has reached 
25mmHg even small increase in volume can lead to marked elevation in ICP, due to 
failure in intracranial compliance or autoregulation. In other words, intracranial blood 
and CSF are the two accommodative components which can compensate for increases in 
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brain volume. When this compensatory mechanism fails, even small rise in volume leads 
to large rise in pressure. Brain compliance can be expressed in terms of a compensatory 
reserve index defined as the ratio of volume change to a pressure change[56].
Cause: Elevation in ICP can be broadly classified by the mechanism that triggers it viz: 
1) increase in brain mass due to tumor, edema, hematoma or a medical condition such as 
liver failure, encephalopathy, etc; 2) elevated blood pressure due to thrombosis,
obstruction, or heart failure; 3) changes in CSF production or drainage as in the case of 
hydrocephalus, meningitis, hemorrhage, or an obstruction in the sagittal sinus. The most 
common medical conditions include aneurysm, traumatic brain injury, brain tumor, 
hydrocephalus, stroke and meningitis. However, brain inflammation is observed in the 
case of chronic implantation of implant/electrodes that arises due to brain tissue-implant 
interaction[2,3].
Symptoms and Treatments: General symptoms of elevated ICP include headache, 
vomiting, nausea, altered consciousness, back pain, blurred vision, high blood pressure, 
behavioral changes etc. Increased ICP is an emergency, and first level of treatment 
includes monitoring the pressure. Treatment depends on the pressure range and other 
clinical symptoms associated with the elevation in ICP. 
Treatment includes various approaches such as neuromuscular blockade / 
diuretics / analgesia/barbiturate, osmotherapy (e.g. IV hypertonic solution or mannitol), 
hyperventilation, improving venous drainage and draining CSF from ventricles of the 
brain or by a lumbar puncture[56].
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Stages of Intracranial hypertension: There are three stages of intracranial hypertension. 
Stage 1 or primary injury includes minimal and gradual elevation of ICP with all the 
compensatory mechanics trying to subside the effect. Beyond this point, compensatory 
mechanisms fails and ICP increases with compromise on neuronal oxygenation and 
vasoconstriction that leads to increased MAP and CPP, which are characteristic events in 
stage 2 intracranial hypertension. Stage 3 has continual increase in ICP, for even minimal 
changes in volume there are dramatic changes in ICP observed. This is due to restricted
blood flow to the intracranial space as ICP approaches MAP and these events overall 
results in increased blood volume in the cranium with elevated ICP and lowered CPP, 
which becomes an iterative process with positive feedback.
Origin of CSF and ICP - Brain and Ventricle Anatomy
The brain, protected by the meninges has a cushion or buffer fluid around and in 
between them called the cerebrospinal fluid (CSF). This colorless fluid gives mechanical 
and immunological protection to the brain 75% of CSF produced by choroid plexus and 
the rest by the surface of the ventricles and subarachnoid space. CSF is routinely 
produced and absorbed while it circulates within the cavities in the brain called 
"ventricles".
Ventricles are a group of cavities having 4 major divisions - two lateral ventricles, 
3rd ventricle and 4th ventricle. The choroid plexus is part of lateral ventricle (foramen of 
Monro), where CSF is produced and circulated through the 3rd and 4th ventricle to the 
brainstem and subarachnoid spaces covering the brain and spinal cord. There are dural 
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sinus and subarachnoid granulation that open out to CSF connections over the outer 
surface of the brain.
Figure 5. Representation of brain meninges 
Correlation with CPP, brain compliance and Equations
ICP is derived from interaction of cerebral blood flow and CSF circulation, which 
can be represented by this equation: 
The vascular component is difficult to define quantitatively, but CSF component 
of ICP can be written as:
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Cerebral perfusion pressure (CPP) is an important factor in maintaining the 
pressure gradient across the cranium, which happens through auto-regulation of cerebral 
blood flow (CBF). CPP is estimated as the difference of mean arterial blood 
pressure(MAP) and mean ICP, which could be expressed as:
ܥܲܲ = ܯܣܲ − ܫܥܲ
When autoregulation fails, ICP has a direct effect on cerebral blood flow. 
Elevation in ICP causes CPP to decreases, which in turn raises the systemic blood 
pressure, increasing cerebral blood flow dilating the vessels. This result in increased CBF 
and ICP further lowers CPP and leads to a vicious circle of events. This causes ischemia, 
infarction and hemorrhages, fatal to the patient[4, 56].
ICP Monitoring - Waveform analysis
ICP waveforms components
Cerebral compliance can be determined by the ICP waveform, so it is highly 
essential to monitor ICP continuously with all the events and shifts recorded. A normal 
ICP waveform follows a sawtooth pattern with three significant peaks - P1, P2 and 
P3[56].
P1 represents the arterial pressure reflection in ICP transmitted through the 
choroid plexus, which are consistent sharp peaks. This is termed a percussion wave.
P2 represents the cerebral compliance and is the variable called tidal wave. If P2 
exceeds P1 in magnitude, elevated ICP is difficult to manage with medical treatment 
indicating failure of cerebral compliance.
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P3 is the dicrotic wave that reflects the venous pressure and the dicrotic notch 
from the arterial waveform.
Figure 6. ICP Waveform Components 
[2]
ICP waveforms types
Lundberg, first classified intracranial pressure variation observed in humans into 
three distinct types A, B and C waves[4, 56].
A-waves, also known as plateau waves are most significant waves, indicating 
decreasing cerebral compliance or high intracranial hypertension. These are seen when 
ICP goes abnormal high 50 to 100 mmHg for 5-20 minutes and then falls abruptly 
representing neurological dysfunction such as hypoxia, ischemia or infarction.
B-waves are often not significant and are rhythmic oscillations occurring every 1 
or 2 minutes associated with respiratory cycle. These represent instantaneous pressure 
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elevation in 20 to 50 mmHg range. These waves do indicate failure in compliance before 
the appearance of A waves.
C-waves are a normal ICP waves up to 20 mmHg that follow arterial pressure 
with frequency of 4 to 8 per minute and signal no pathologically significant failure, i.e. 
they demonstration everything is normal.
Figure 7. ICP Waveform Types - A, B and C 
[72]
Spectral Analysis
Analysis of ICP is a whole field of research. ICP analysis, commonly known as 
high-frequency centroid analysis is based on the power spectrum of a single pulse ICP. 
The frequency component of ICP ranges from 5 Hz to 15Hz, with dominant fundamental 
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peaks representing slow and respiratory cycle waves. A standard power spectrum of ICP 
is as shown below.
The waves - slow, respiratory and pulsatile ICP waves overlap in the time 
domain and hence, cannot be visualized. In the frequency domain representation, they are 
clearly separated. The literatures describes the use of the power spectrum analysis of slow 
waves form as a predictor for intracranial hypertension and low magnitudes in the slow 
waves are associated with failure of autoregulation, resulting in fatal events[57].
Figure 8.  ICP Spectrum [4]
Sensors
Force Sensitive Resistors 
Force sensing resistors (FSR) are conductive polymers, whose resistance changes 
are indicative of the force or pressure applied on the surface[58, 59]. The FSR technology 
was invented by Franklin Eventoff and patented in 1977. Interlink electronics was 
founded by Eventoff in 1987 based on this technology and later Sensitronics became the 
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leader in this technology, which is his company founded in 2001. FSRs are commercially 
available as sensors or sheets that can be customized for the application of interest. These 
are also available as pressure sensitive inks in certain countries to screen print on the 
substrate. The pressure sensitive ink consists of both conductive and non-conductive 
particles in a matrix suspension. The choice of conductive material, non-conductive 
material and the suspension depends upon the application and the manufacturer.
Principle:
The sensor used in this work operate on the principle of piezoresistivity, which is 
change in resistance due to a change in mechanical force applied over the sensing area. 
This change in resistance can be measured as a change in voltage to quantify it. 
Advantages of using FSRs is that they can tolerate hostile environments, are low cost,
and have good shock resistance. They were also chosen for their low profile compatible 
with human physiology for epidural or subdural monitoring, the thickness is usually less 
than0.5mm.
Construction:
The sensor has two pressure sensitive layers on a flexible PET substrate with a 
screen printed conductive pad extending from sensing area to connection port. The 
sensing layer is an ink having both conductive and non-conductive microparticlesin a 
matrix. Sandwiched between the layers on the periphery is a very thin material called 
“spacer”, whose thickness determines the minimum force required to activate the sensing 
property[60]. There are two types of FSR based on construction: ThruMode and 
ShuntMode
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1) ShuntMode: In this type of FSR construction the resistive ink material is 
printed on one film and the interdigitated pattern of conductor on the other, then both are 
put together facing each other with a spacer in between or on the periphery. 
2) ThruMode: This is another type of FSR construction, where both the films have 
resistive ink material printed over a solid conductor printed on the substrate. 
Figure 9.  Construction of ShutMode FSR [67]
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Figure 10.  Construction of ThruMode FSR [67]
In general, ThruMode FSRs are more sensitive than the ShutMode FSRs. 
FlexiForce and Sensitronics FSR were investigated for low pressure application. 
Sensitronics' Force Resistive Sensors were more sensitive for our application and were
chosen for investigation.
MicroElectroMechanical Systems (MEMS) Sensors
MEMS technology is fast growing, and its biomedical applications has been vast. 
Owing to their micro-scale structures and features, and ease of integration with
siliconelectronics, MEMS are poised to maintain enormous growth in biomedical 
devices. Within these MEMS devices for biomedical applications there is a large research 
focus on piezoresistive technology. We have selected one such device for this work. 
Measurement Specialties disposable blood pressure transducer was chosen in our
investigation of sensors for brain pressure monitoring.  Model No:1620 with MEMS die 
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is batch manufactured and available in a 10x12 element array with antistatic protection 
for commercial use[68].
Construction:
This is a fully piezoresistive silicon pressure transducer is used for invasive blood 
pressure monitoring and calibrated per the Association for the Advancement of Medical 
Instrumentation (AAMI) standards.  This sensor has a MEMS die of 2x2 mm square, 
mounted on a ceramic substrate with a plastic encasement and a cup extension over the 
sensing area, where the die is exposed for sensing purposes. A silicone dielectric gel over 
the die in the cup provides electrical and fluid isolation. 
Figure 11.  Dimensions of the MEMS Sensor [68]
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Figure 12.  Construction of the MEMS Sensor  [68]
Features and Application: 
This miniature transducer is low-cost and designed for medical application complying 
RoHS regulation. This device is designed for invasive blood pressure and intrauterine 
pressure monitoring. The sensitivity is typically 5uV/V/mmHg with range of 
measurement -50 to 300 mmHg and frequency response 1200 Hz. This is an active 
transducer and requires a voltage supply to function. The operating lifetime is 168 hours 
or 7 days with shelf life of 5 years.
Principle and Working: 
The sensor works like a strain gauge with the MEMS die within. The changes in pressure 
are reflected as changes in resistance that can be quantified. From resistance formula,
so for changes in material dimensions (length or area) the resistance either increases or 
decreases indicative of the strain/pressure applied over it. This transducer has four such 
resistances allowing a Wheatstone bridge configuration, where two transducers increase
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in resistance while other two decreases with incident pressure.This configuration 
increases the gain of the system, increasing accuracy.
Figure 13.  Sensor pins internal connection - equivalent circuit [68]
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CHAPTER 4
METHODOLOGY
Research Trajectory
My research, which started with investigation a very specific problem, later 
turned out to be a great solution for general low-cost brain pressure monitoring. Thus, the 
system was tested in such a manner that we could conclude on its performance generally, 
rather than solely as an augmentation of an ECoG array.
Initial investigation: Force sensing resistors (FSR) were initially investigated as a 
pressure sensitive device for measuring the pressure in the range of 0-100 mmHg. 
Commercial FSRs are used for higher pressure ranges (0.5 - 50 psi), thus generally 
measures beyond 25.86 mmHg pressure. For the purpose of evaluating low pressure 
changes, modification in the sensing area was necessary. Sandwiched between the two 
layers of the pressure sensitive layer, is a spacer material, the thickness determines the 
minimum force required to activate the sensor. This technical aspect was explored while 
interacting with the inventor of this technology Mr. Franklin Eventoff. I utilized this 
concept for my study and the spacer material was changed for low pressure application. 
This is a novel approach and in the intensive literature review that I performed, there is 
no record of this concept or of the sensor being utilized for an ICP monitoring 
application. I studied Sensitronics’ FSR without and with a thinner spacer material. The 
results were not highly satisfactory due to the non-uniform dispersion of ink and part to 
part variability that was magnified in the low pressure range. So, further experimentation 
on these sensors were suspended.
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Further investigation: Having the main focus on piezoresistive technologies for 
intracranial pressure sensor, Measurement Specialties’ disposable blood pressure sensor
was considered next for testing. The fact that this sensor has been on the market and has 
been utilized by various companies to manufacture extravascular blood pressure 
transducer catheters (which are approved by FDA) showed the efficacy of this sensor. 
Further, the dynamic range of this transducer is broad enough to measure ICP changes 
and follows the AAMI specification for ICP monitoring. Additionally, literature study 
indicated no substantial use of this transducer for epidural intracranial pressure 
monitoring. These findings were encouraging with respect to the use of the sensor for 
ICP monitoring, and we believe this is a great solution to ICP monitoring. Therefore, to 
secure a proof of concept an epidural ICP monitoring system was developed, with an aim 
to integrate it with the ECoG electrodes in future. This was achieved by modifying the 
sensing area. A sensing cup attachment was made at the site of sensor's original sensing 
area. Sensing cup was glued with super glue to the sensor. The experiments described 
below were performed and evaluated with this sensing cup extension.
Design and Working
FSR
(i) Sensor Modification: Spacer material is typically an adhesive membrane that acts as a 
double-sided tape. These membranes are commercially manufactured by 3M. 
Sensitronics' one inch ThruMode FSRs were used for my research, which had a 0.13mm 
thick spacer material. This 0.13 mm thick spacer (3M 7945MP) was replaced by a 0.09 
mm thick spacer (3M 7953MP) material for the low pressure application to reduce the 
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threshold pressure of actuation. This construction, property defines the operating range of 
these sensors[67].
Figure 14. Spacer construction with material specification[69]
(ii) Circuit Design for Implementation: Resistance changes in the sensor are indicative of 
the pressure variations over the sensor and measurement of this dynamic variation 
requires a circuit. This readout circuit could be a voltage divider or bridge circuit. For 
simplicity a voltage divider was chosen; it consists of a 2 V supply voltage, a fixed 
resistance of 100 Kohms in series with the FSR, which acts as a variable resistor
depending on the applied pressure. The output voltage increases as the resistance of FSR 
decreases. This relationship can be quantified by the equation below from Ohm's law:
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ܸ݋ݑݐ = ܸ݅݊ ∗ ܴ(ܴ + ܨܴܵ)
The output from the circuit board was directly connected to the computer through a data 
acquisition (DAQ) system hardware (Measurement Computing USB 1408FS) interfaced 
with a real-time acquisition program in MATLAB written as a part of this research, 
specifically created for this application.
Figure 15. Block diagram and circuit diagram of FSR based pressure system
Figure 16 showing the sensor's behavior during loading/application of force 
demonstrating the relationship between the resistance and pressure. With no load or 
application of any pressure over the sensor, the resistance is very high on the order of 
several thousand kohms and on loading decreases according to the pressure applied.
Note: The plot isn't a calibration graph as the parameters and construction is modified in 
this work.
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Figure16. Example response of the sensor[70]
MEMS Sensor
(i) Sensor Modification: The sensing area requires a physical modification to provide 
access into the epidural space. The sensing cup extension or packaging is specific for the 
implementation model considered. However the geometry of this model used is capable
of enabling implementation on another model. Here it is executed for an epidural 
application in rats.
A sensing cup (as show in the figure below) is a conical tapering polypropylene 
pipette tip cut down under a microscope to exactly fit the outer diameter of the sensing 
area projection on the sensor. This cup is designed for a rat craniotomy having 2 mm drill 
size, where an opening of 1.7 mm is exposed inside the rat skull, which is <1 mm deep 
(the skull thickness) from the access point of2 mm diameter of the cup that fits on the 
skull as shown in the figure 17. The sensor is attached at the end with the larger opening 
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as seen in figure 18 and the sensing pocket/cup is filled with saline as the incompressible
pressure transmitting medium before the implantation or testing.
Note: The sensing cup directly fits onto the head and is sealed directly onto to the skull 
with no bolt requirement.
Figure 17. Sensing cup dimension
Figure 18. Sensor modified with sensing cup attachment
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(ii) Circuit Designed for Amplification and Processing: The sensitivity of the transducer 
is 5uV/V/mmHg, representing the need for voltage amplification to accurately measure 
pressure changes. The transducer needs a voltage supply, which here is fixed at 6V 
making the calibration factor 0.030mV/mmHg for reconverting the voltage to pressure 
values. The circuit designed has two main parts, a voltage regulator that provides a 6V 
supply to the sensor from a 9V battery and an amplifier with a 1000X (or) 60db gain. To 
avoid noise, the whole circuit runs on battery power, which also makes the system very 
portable.
The voltage regulator circuit uses LM317 IC, capacitors, and resistors, to provide 
a 6V output from a 9V battery. This supply goes to the positive voltage pin of the sensor, 
the positive and negative voltage outputs of the sensor are given to the respective pins of 
the amplifier chip. The negative pin of the sensor is grounded with respect to the 6V DC 
supply for the sensor.
Figure 19. Voltage regulator circuit
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The amplifier circuit consists of an instrumentation amplifier INA101, resistors, 
power supplies and potentiometer. The gain is set with a single resistance across pin 5 
and pin 10, which is calculated from the equation below:
ܩܽ݅݊ = 1 + 40ܭΩܴ݃
where, Rg is the resistance fixed to obtain the desired gain. Here, Rg is set as 40Ω to 
have a gain of 1000 to convert the mV to V. The IC requires a supply of min ±5V and in 
the design ±9V is provided at pin 2 and 13 respectively. The output from pin 1 and 14 
runs to the DAQ that is interfaced with a real-time acquisition program in MATLAB 
specifically created for this application. Pin 14 is grounded and common ground exists 
between amplifier and voltage regulator circuit to avoid any noise in the output. Pins 6 
and 7 are given to a 100kΩ null potentiometer to provide an offset adjustment by the 
user, which can control the baseline offset that pressure transducer may have. Also, the 
center pin of the potentiometer is connected to a positive supply. Below is a figure 
showing the pin diagram of the INA 101 instrumentation amplifier and the circuit 
connections.
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Figure20. Pin connections and amplifier circuit[71]
Figure 21. Block diagram of the sensor and electronics
53
Experimental Procedure
Bench Tests 
Calibrationof the FSR:
Calibrated Weight Test: Calibrated weights from 1g to 350g were placed on the 
sensing layer with an acrylic disc to uniformly distribute the pressure over the area. 
Weights were added in increments of 1g from 1g up to 20g, and then in increments of 5g 
from 20 g to 50 g, and 10g from 50-350g; this procedure is considered one experiment 
With the readings observed, a calibration graph was plotted for equivalent pressure for 
these weights versus the output voltage. Three sets of calibration experiments were 
performed to determine the calibration parameter used in the signal reconversion 
program. The setup is developed based on previous studies for the same sensor[61, 62].
Figure 22. Calibration Test Setup with Weights
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Measurements with the FSR:
Water Column Test: 
A 90 cm long acrylic column with the sensor's sensing layer taped down onto an 
acrylic plate was constructed for this test. The set up was sealed at the junction of the 
column and the acrylic plate on which the sensor was taped down. Epoxy putty was used 
for sealing around the perimeter to prevent any leaks. The other end of the column was
partially closed during experimentation with openings only for the tubes to purge in water 
for evaluation. Water was purged manually in steps of 1 cm to a height of 60 cm and 
equivalent pressure values were calculated. Three initial experiments were performed to 
determine if the calibration range in signal reconversion program matches the 
measurement obtained in these trials. Discrepancies usually occurred due to slight tilt in 
the water column. This happens due to the pressure water exerts on the side walls as 
water is added in. This error was corrected by manually leveling the system with a bull's 
eye leveler. Once error-free and calibrated, three sets of measurement experiments were 
performed. The setup was developed based on previous studies with the sensor[63].
Figure 23. Water column measurement setup
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MEMS Sensor Calibration:
1) Sensor Calibration: The first time the sensor is removed from the manufacturer's 
packaging, the sensor is calibrated as per the manufacturer's recommended calibration 
technique. A 150kΩ resistor is connected between the positive voltage output pin and the 
supply input pin of the sensor, which must provide equivalent voltage for 100 mmHg, 
which is 0.030mV for a 6V supply. But, in practice 0.029mV was observed for a 5.89V
supply voltage.
Figure 24. Calibration of the sensor
2) System calibration: This calibration was performed to determine if the calibration 
factor set in the voltage to pressure reconversion program is accurate. Sensitivity 
according to the manufacturer is typically 5uV/V/mmHg, and ranges between 4.95 
uV/V/mmHg to 5.05uV/V/mmHg. The calibration factor, in the reconversion program is 
set based on this sensitivity multiplied by the supply voltage. For a 6V supply, calibration
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factor is 0.030mV/mmHg, but in practice it is set as 0.02945mV/mmHg for an observed 
sensor supply voltage of 5.89V.
A centrifuge tube was used to provide a static water level at a particular height,
used to calculate the pressure exerted by the column of water over the sensor. This true 
calculated pressure was compared to the pressure measured by the sensor. Any errors or 
baseline shifts obtained at this stage are adjusted to obtain an error free reading. Below is 
the figure illustrating the setup described, in which the opening of the centrifuge tube is 
customized to exactly fit onto the sensing cup. The distance from the opening of the 
centrifuge tube to the opening of sensing cup is measured as 11 cm and the height of the 
sensing cup is 1 cm. Thus, the setup can measure a maximum of 12 cm water height or 
8.8mmHg. Three values of static pressure (2mmHg, 4mmHg and 8mmHg) were 
measured to check our measurement against calibration or actual pressure.
Figure 25. Experimental setup of water column for system calibration
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MEMS Sensor Measurement:
1) Static Pressure Test: This test was accomplished using the centrifuge tube with water 
to measure pressures from 0 mmHg to 8mmHg. The above mentioned water column 
setup was utilized for this experiment and three experiments were performed with 
pressure steps of 0.5mm Hg.
2) Dynamic Pressure Test: This test was performed to qualitatively evaluate the response 
time of the system. Since, there was no delay element added in the system, it was 
assumed to work per manufacturer's determined frequency response of 1200Hz, implying
that the response time is approximately 1ms. This setup consists of a sphygmomanometer 
with a centrifuge tube attachment instead of a standard blood pressure cuff. The 
centrifuge tube is customized to provide access to the sensor via the sensing cup. The 
medium used for this test is air. The experiment is performed by pumping and releasing 
the air, though the bulb of the sphygmomanometer. Each set of experiment consists of a 
pump and release cycles equally timed every second for one minute. Three sets of 
experiments were performed
Figure 26. Dynamic Pressure Evaluation Setup
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3) Media Test: The static water level setup was used for this experiment with saline to 
determine the effects of an electrically conductive media on the system, if any. Phosphate 
Buffer Saline (PBS) 10X and 1X were used to test with a medium having nearly 
equivalent characteristics of physiological saline. Pressure measurements from 0-8 
mmHg with steps of 0.5 mmHg were performed, and three sets of such experiments were 
repeated.
Animal Model Test
Surgical setup and procedure:
The animal model used for this study was rattus norvegicus. The animal was 
anesthetized with a ketamine/xylazine/acepromazine cocktail, and then the animal was 
placed on 1-3% isoflurane gas through a nose cone mask. The animal’s head was shaved, 
and the surgical site was prepared with a betadine scrub followed by isopropyl alcohol 
rinse, repeated 3 times. The animal was then mounted onto a small animal stereotaxic 
mounting apparatus on a heating pad and covered with a sterile drape, and eye lubrication 
was be applied. A tail catheter was placed to deliver hypotonic saline and mannitol. An 
incision was made with a sterile #10 blade along the midline extending from just behind 
the eyes to the base of the neck. The scalp was retracted and the bone was cleaned of the 
periosteum. A 2 mm diameter craniotomy was performed using a surgical drill. 
Once the sensor is in its desired position, cyanoacrylate was used to secure the 
sensor to the skull. The intracranial pressure was recorded and manipulated as described 
below. The animal was euthanized following the experiment.
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Experimental procedure:
Table 1
Tabulation of experiment procedure followed in animal model testing
Indication/Expected 
Response
Drug/Manipulations
Infusion/procedure 
time
Data collection 
time
Baseline ICP None None 4minutes
ICP Variations
Mechanical 
Compression
2 minutes with 
compressions every
10seconds
2 minutes 
repeated 3 times
Increase  in ICP Hypotonic Saline 3 minutes 5 minutes
Decrease in ICP Mannitol 8 minutes 2 hours
After the craniotomy, the sensing cup was filled with saline and any offset due to 
this cup hold saline (~ 0.8mmHg) was reset to zero. A final check of the sensor with the 
sensing cup was performed for calibration and error using the sphygmomanometer to 
measure 0-20 mmHg; this is done just prior to introducing the sensing cup into the skull. 
The sensor and the sensing cup filled with saline were turned upside down and placed 
into the rat's head reaching its dura. Since, the sensing cup is customized for a 2mm burr 
hole to fit the skull with 1.7mm diameter opening for pressure contact, given the skull 
thickness is about 1 mm. The wire connections from the sensor were taped down over the 
sterile drapes covering the rat's body for stability, preventing jolting of the sensor. Once, 
the baseline pressure value correlating to the heart rate was observed, confirming the 
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sensor was working properly, the sensing cup was sealed onto the skull with cyanoacrylic
glue. 
The mechanical compression procedure involved timed compressions of the rat's
abdomen or thorax every 10 seconds for 2 minutes. This procedure was adapted from 
various literatures demonstrating the ability to change ICP in accordance with 
compression (increases ICP) and relaxation (returns to baseline ICP).
Hypotonic saline was injected to bring about an increase in ICP. A 40 ml/Kg 
0.45% hypotonic saline was introduced through the tail catheter while ICP was 
recorded.The expected response time for hypotonic saline is under 2 minutes. Thus we 
observed the ICP for 5 minutes following the initiation of the bolus.
Mannitol was injected to bring about a decrease in ICP. Mannitol was injected 
after 5minutes from the end of hypotonic saline injection. This was injected over 8 - 9 
min interval and ICP was expected to start falling 20 minutes from end of mannitol 
injection. See Appendix 1 for a photograph of the implanted sensing cup.
Figure 27.  Animal model Experimental Setup
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CHAPTER 5
OBSERVATION AND INFERENCE
Bench Test FSR
Calibration
The force sensing resistor was modified to decrease the range of sensitivities to 
match the ICP range by replacing the spacer material with a thinner spacer. After spacer 
modification, the FSR  was calibrated with known weights. This procedure involved 
calculation of pressure from the weights,given the area of the sensor. Calculations, are as 
follows:
We know that, 
ܣݎ݁ܽ = ߨݎ2
݀݅ܽ݉݁ݐ݁ݎ (݀) = 1݅݊ܿℎ = ʹ5.4 ݉݉
ݎܽ݀݅ݑݏ (ݎ) = ݀ʹ = ʹ5.4ʹ ݉݉ = 1ʹ.7 ݉݉
Therefore,
ܣݎ݁ܽ = 3.14 × (1ʹ.7)2 = 506.45 ݉݉2 = 0.506 × 10ିଷ݉2
ܲݎ݁ݏݏݑݎ݁ (ܲ) = ܨ݋ݎܿ݁ܣݎ݁ܽ = ݉ܽݏݏ × ݈ܽܿܿ݁݁ݎܽݐ݅݋݊ܣݎ݁ܽ
Where, 
݈ܽܿܿ݁݁ݎܽݐ݅݋݊ = 9.8 ݉/ݏ2
݉ܽݏݏ ݒܽݎݎ݅݁ݏ ܾ݁ݐݓ݁݁݊ 1 ݃ − 350 ݃
ܲ = ݉ܽݏݏ × 9.80.506 × 10ିଷ  ܰ/݉2
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This estimates the pressure over the sensor and serves as calculated pressure. The 
voltage during each weight increment is noted and plotted on the calibration curve.
The increments were 1g from 0-20g and 5g from 20-50g and 10g from 50-350g.
A voltage versus estimated pressure is plotted and a nearest polynomial fit was 
used to determine the calibration equation for pressure reconversion during 
measurements. The data observation followed a fifth order polynomial equation as 
follows:
ܲ = 33ܸହ + 14ܸସ − 90ܸଷ + 51ܸ2 + 14ܸ + 19
The figure below shows the nearest polynomial fit for the observed voltages and 
the respective pressures. This polynomial fit equation is used to estimate the pressure 
over the sensor when a voltage is measured to determine  the piezoresistive change 
brought about by a change in pressure.
Figure 28. Calibration plot of FSR.
63
This plot represents the voltages observed for the respective applied pressure; The 
data was fit with a polynomial curve of fifth order. This equation is used to determine the 
intracranial pressure during measurements.
Measurement
Three sets of experiment were performed to measure 0 - 50 mmHg in increments 
of 0.7 mmHg or 1cm height of water level. And the pressure observed in the three sets of 
experiment averaged.
Pressure due to water increments in the column is calculated to find the estimated 
pressure as below.
ܲ = ߩℎ݃
Where, P = pressure (pascal); ߩ= density of water, which is 999.9 kg/m3; h=height of 
water in the column (m); g=acceleration due to gravity, which is 9.8m/s2
ܲ = 999.9 × ℎ × 10ି2 × 9.8
    = (97.99 × ℎ) ܲܽ
       => ܲ = 97.99ℎ133.3ʹ  ݉݉ܪ݃ = (0.7ℎ) ݉݉ܪ݃
The converted/measuredpressure is plotted with the calculated pressure to find the 
deviation in the readings. It's important to note that the measured pressure is based on the
polynomial calibration equation. Below is a figure of measured voltage against the 
calibration curve representing the overall qualitative repeatability in the measurement of 
the sensor.
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Figure 29. Voltage measurement plot of FSR
This plot represents the measured voltage versus the estimated pressure with the 
calibration curve.
Figure 30. Measurement output plot of FSR
This plot represents the deviation of the pressure measurement from the actual value
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Discussion
Force sensing resistors were fairly satisfactory in measuring and estimating the 
applied pressure. The commercial FSR with the standard spacer has lower limit of 
pressure sensitivity starting at 25.9 mmHg. With the spacer modification, the same FSR 
was able to detect pressure starting from 5.1mmHg. However, the AAMI standards for 
ICP monitoring demands the device dynamic requirement to be 0-100 mmHg. Since, the
FSR with spacer modification has a limit of detection starting at 5.1 mmHg, this pressure 
transducing material cannot be used for an ICP sensing application. Nevertheless, if the 
sensitivity could be improved using a thinner spacer (<1.5mil), this could be used for ICP 
measurements provided the resolution and error characteristics of the transducer satisfy 
AAMI standards.
Further, part to part variability was magnified in the lower pressure range, which 
could be attributed to the non-uniform dispersion of pressure sensitive ink as the 
commercial preparation is not meant for low pressure application. Accounting to low 
sensitivity and high part to part variability, further experimentation with the FSR was 
suspended.
Bench Test - MEMS Piezoresistive Sensor
Calibration 
Sensor Calibration: 
The sensor was calibrated as per the manufacturer's recommended procedure by 
connecting 150kΩ resistor between the supply and the positive output pin. This provides 
an output voltage equivalent to 100 mmHg, which was 2.945 V for a supply voltage of 
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5.89V. The voltage divider was designed to provide 6V, but in practice it provided 
5.89V. The sensor calibration factor / sensitivity was observed to be 5uV/V/mmHg, 
exactly following manufacturer's typically specification. The value was calculated as 
follows:
ܵ݁݊ݏ݅ݐ݅ݒ݅ݐݕ ݏ݌݂݁ܿ݅݅݁݀ = 5 ߤܸ/݉݉ܪ݃
ܵ݁݊ݏ݅ݐ݅ݒ݅ݐݕ ݋ܾݏ݁ݎݒ݁ݎ݁݀ (ܵ) = 5 ߤܸ݉݉ܪ݃ ; ݓ݅ݐℎ ܽ 60ܾ݀ ܽ݉݌݈݂݅݅݁ݎ 5 ܸ݉݉݉ܪ݃
ܵ = ܱݑݐ݌ݑݐ ܸ݋݈ݐܽ݃݁ ݂݋ݎ 100 ݉݉ܪ݃ܲݎ݁ݏݏݑݎ݁ ∗ ܵݑ݌݌݈ݕ ܸ݋݈ݐܽ݃݁ = ʹ.945100 × 5.89 = 5 ܸ݉
=> ܥ݈ܾܽ݅ݎܽݐ݅݋݊ ݂ܽܿݐ݋ݎ = ܵ × 5.89 = 0.0ʹ945 ܸ/݉݉ܪ݃
So as calculated, 0.02945V/mmHg for the supply voltage provided is set as the 
calibration factor to convert the voltage observed into pressured measured by the sensor.
System Calibration: 
This is performed with the water column to check the accuracy of the calibration 
factor.  Four specific water levels (2 cm,4 cm,6 cm and 8 cm) are considered to provide 
pressure over the sensor. Each water level, i.e. pressure applied is repeated thrice to 
estimate the error due to calibration. The aim of this procedure was also to determine 
whether the sensor is sensitive below 5 mmHg as specified by the manufacturer.
Below is a table of the calibration measurements and observed voltage outputs 
after amplification.
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Table 2
Tabulation of sensor output for system calibration
Height of 
Water in 
column 
(cm) 
Pressure 
(mmHg)
Voltage V1 
(V)
Voltage V2 
(V)
Voltage V3 
(V)
Averaged 
Voltage 
Observed 
(V)
2 1.5 0.0442 0.0434 0.0447 0.0441
4 2.9 0.0855 0.0864 0.0856 0.0858
6 4.4 0.127 0.131 0.132 0.13
8 5.1 0.172 0.171 0.175 0.173
Further, a calibration graph was plotted as shown below with the standard error at 
observed at that particular pressure.
Figure 31. Standard error plot of system calibration.
This plot represents the standard error in measurement for the fixed calibration factor 
determined by sensor calibration.
An important process to note here is, the offset adjustment for the sensor is a 
manual intervention, which has significant control over the system reading and 
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calibration. So, this system calibration was repeated until the standard deviation was 
reduced to < 0.001V for all the specified pressures taken for observation.
Measurement
1) Static Test - Water column
The same setup was used after system calibration, ensuring no error was 
attributed due to setup changes. Pressures from 0-8.8 mmHg were applied in increments 
of 0.7 mmHg. Below is a plot of pressure measured versus the pressure estimated, 
showing the accuracy of the sensor.
Figure 32. Static pressure measurement plot
This plot of pressure measured versus the actual pressure, representing the accuracy of 
the sensor for static measures
2) Dynamic Test - Air Pump
In this test, manually pumping a bulb provided the estimated pressure over the 
sensing area. This test involved approximation errors, since the procedure was to 
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manually pump the air to a certain pressure and at no point it was guaranteed that applied 
pumped pressure exactly reached the estimated pressure. The estimated pressure is 
determined by a pressure gauge with a resolution of 2 mmHg, indicating there could be 
an error of ± 2 mmHg in the applied pressure with respect to the pressure estimated.
The overall goal of this test was to qualitatively estimate the dynamic response of 
the sensor, i.e. if it measures pressure without any significant delay in the response. 
Applied pressure varied from 0-10 mmHg by manual pumping of air with an aim of 
providing at least two pumps per second. The figure below shows the output pressure 
measured inthis experiment. 
Figure 33. Dynamic pressure measurement plot showing the dynamic response of the 
sensor for a manually varied pressure over 4 seconds.
3) Media Test
This test was a static measurement that involved a liquid of different density and 
conductivity than water. This was performed as a conformational test before animal 
model testing due to similar media environment. Phosphate buffer saline was used as a 
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physiological media equivalent to perform this test. The pressure was varied from 0-8.8 
mmHg and the figure below shows the response of the sensor for this experiment.
Figure 34. Static pressure measurement plot with saline media.
Discussion
This MEMS sensor, having dynamic range -30 to 300 mmHg is greatly accurate 
for an ICP application considered. The efficacy of the sensor ensured by the existing 
commercial application of this sensor for invasive blood pressure monitoring. However, 
the experimental setup, calibration and measurement were performed to estimate the error 
and offset adjustment required with the readout electronics used in our system before 
implementation in an animal model for ICP monitoring. The sensor after system 
calibration and adjustments, had a 0.1 mmHg accuracy on the benchtop, 2% error, 0.01 
mmHg resolution and 0.1 mmHg precision.
The characteristics of the sensor were excellent for ICP monitoring and further 
experimentation with this sensor continued with the animal model implantation.
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CHAPTER 6
RESULTS AND DISCUSSION
The animal study involved observing the baseline ICP, mechanically varying the 
ICP by abdominal compressions and varying the ICP by physiological perturbations with 
injections capable of resulting in a tonicity changes.
The experiment was conducted following the IACUC guidelines and approved
protocol. Real time data observation determined the successful implantation of the sensor 
to the desired level of penetration or depth below the skull while remaining above the 
dura. As soon as the sensing cup was placed with its opening inside the skull over the 
drilled open area, a baseline ICP signal was observed which correlated with the heart rate 
at that point of time. This confirmed the implantation location and depth was appropriate
for ICP measurements. After proper placement was confirmed, the sensing cup was 
sealed on to the skull to avoid fluid leakage and to obtain steady state conditions for 
accurate pressure measurements.
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1) Real-Time Baseline ICP
Figure 35. Baseline ICP, before and after filtering
The figure above shows the baseline ICP measured over one second, in which 60 
Hz noise is observable in real-time, unfiltereddata. The raw signal with power line 
interference was filtered using a Butterworth low pass filter with a cutoff frequency of 
30Hz. The average heart rate of a rat ranges from 240-490/minute, which translates to 4-
8.1 Hz. These low frequency components are dominant signal observed.
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2) Analysis Plots
Figure 36. FFT of the ICP signal before filtering
The above figure is a plot of the frequency spectrum of the measured ICP signal. 
The plot has clearly observable noise components and lower frequency components
(including DC), which are our signals of interest. This spectrum is generated from 200 
seconds data that covers a range of heart rates from 199-255 bpm. Due to heart rate 
variability, we observed a set of low peaks around 4-5 Hz.
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Figure 37. Filter characteristics of a Butterworth filter
The above figure represents the 30Hz cutoff implemented using a 10th order 
digital Butterworth filter.
Figure 38. FFT of the ICP signal after filtering
The above figure is plotted to confirm the noise above 30 Hz is removed 
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Figure 39. FFT of the ICP signal at a certain heart rate
This plot shows the frequency peak correlating to the heart rate observed at that 
time, which clearly indicates a good signal strength.
3) Baseline intracranial pressure data for over one second
Figure 40. Baseline ICP for heart rate of 220 bpm
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The ICP signal's magnitude or DC content represented the baseline pressure 
inside the rat's brain at any given instance in time. The frequency of the ICP signal 
follows and correlates with the heart rate at that point, which is 220 bpm in this case.
Figure 41. ICP over one second at different physiological conditions
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4) Experimental Perturbation Data
Figure 42. ICP variation due to Mechanical Compression 
A manual mechanical compression procedure was used to vary the ICP. The 
target was to provide compression every 10 seconds, however manual variations and 
reaction time is observable in the timing of compression and relaxation. The plot above 
shows a great correlation in ICP for mechanical compression and relaxation protocol.
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Figure 43. Filtered infusion data
The above figure shows the overall experimental infusion cue. The peaks 
correlate with the injection times and in turn serve as a visual indicator of the 
physiological changes.
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Figure 44. Hypotonic saline injection and elevation in ICP 
As seen in the figure above, after injection of hypotonic saline, there is an
increase in the baseline ICP level. This demonstrates the responsivity and efficacy of the 
system. 
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Figure 45. Mannitol injection results
Mannitol was expected to lower ICP, but instead ICP increased. ICP neither 
returned to baseline nor decrease. While we can only make conjectures as to the cause of 
this behavior, we can offer two hypotheses:
1) Hypotonic saline volume injected was too high, elevating the ICP much more 
than the level expected. Due to this large volume, the ICP could no longer be reduced 
with Mannitol infusion. Additionally, the volume is increased with any infusion and this 
could actually be increasing ICP further
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2) Effective time for mannitol to decrease the pressure might be several hours, 
which was out of our range of experimentation time that we could not observe any 
response. 
Discussion
The results of the animal model experiments provided confidence that we can use 
this system to observe ICP. With the exception of mannitol infusion, which did not 
produce the desired effect of decreasing ICP, the functioning of the system was highly 
satisfactory and as expected. Nevertheless, after euthanasia, the varying pressure waves 
disappeared and just a baseline static pressure was observed. This stated that sensor was 
still working great after mannitol infusion. The aim of evaluation and testing the efficacy 
of the system was accomplished. The system had good accuracy and repeatability in 
measuring ICP without any significant delay. 
Interestingly, the real-time ICP signal had a very high power line noise, although
the whole system was battery powered. It is suspected that the noise coupled from the 
pulse oximeter probe attached to the rat's foot for measuring the vital parameters during 
the surgery. Another exciting observation was that, ICP monitor was faster in detecting 
any changes in heart rate or reaction to changes in anesthesia settings, than the pulse 
oximeter. These real time observation further justify the system functionality and bolster 
its potential as ICP monitor.
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CHAPTER 7
CONCLUSION AND FUTURE SCOPE
Intracranial pressure was successfully monitored and analyzed in rats, by our 
epidural ICP monitoring system.
This ICP monitoring system was designed using a commercially available 
pressure transducer intended for biomedical applications. This transducer is a disposable 
blood pressure sensor used in extra vascular catheters for invasive blood pressure 
monitoring. This sensor was adapted to develop an epidural ICP monitoring system due 
to the characteristics of the sensor that were well matched with the requirement. After the 
system design, calibration and successful bench testing, the system was taken for the next 
level of testing in animal model - rattus norvegicus (Rat).
The result from the rat model showed the efficacy of the sensor for an epidural 
ICP application and demonstrated this system can continuously measure ICP. The ICP 
signal observed had good correlation with the physiology. The signal clearly had a 
baseline ICP value and its frequency correlated with the heart rate at that instance, 
throughout the experiment, which is a typical characteristic of an ICP signal. The results 
of ICP variations induced by mechanical compressions of the abdomen or by 
involvement of physiological drug infusion, served as an evidence that this system could 
potentially detect ICP variations accurately, repeatably and without any significant delays 
involved. 
Further, the system followed the AAMI standard specification for intracranial 
pressure monitoring viz:
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1) Dynamic pressure measurement range of 0-100 mmHg 
2) Accuracy of ±2 mmHg in 0-20 mmHg range
3) 10% maximum error in 20-100 mmHg range
Thus, this research work is a proof of concept for a monitoring system that could 
provide a minimally invasive, highly accurate ICP recordings. This work also sets the 
stage for an integrated system design.
The sensor uses a MEMS die that acts as a strain gauge and measures the pressure 
changes. With integrated electronics and MEMS technology, this die could be embedded 
as a chip on an ECoG electrode array, which would be an elegant and highly effective
solution to monitoring brain pressure in the presence of brain implants or electrodes. 
Further, this technology is a simple and lower cost than any of the commercially 
existing intracranial pressure monitoring systems available in the market today. Thus we 
believe this system has the potential to transform monitoring of intracranial pressure for 
both minimally invasive monitoring and ECoG applications
84
REFERENCES
[1]"Statistics on TBI" US Centers for Disease Control and Prevention. 
Web:<http://www.cdc.gov/traumaticbraininjury/pdf/BlueBook_factsheet-
a.pdf>
[2] Raboel, P. H., et al. "Intracranial pressure monitoring: invasive versus non-invasive 
methods—a review." Critical care research and practice 2012 (2012).
[3] Pattinson, Kyle, Guy Wynne-Jones, and Christopher HE Imray. "Monitoring intracranial 
pressure, perfusion and metabolism." Continuing Education in Anaesthesia, Critical Care & 
Pain 5.4 (2005): 130-133.
[4] Czosnyka, Marek, and John D. Pickard. "Monitoring and interpretation of intracranial 
pressure." Journal of Neurology, Neurosurgery & Psychiatry 75.6 (2004): 813-821.
[5] Matsushita, Kojiro, et al. "Development of an implantable wireless ECoG 128ch 
recording device for clinical brain machine interface." Engineering in Medicine and Biology 
Society (EMBC), 2013 35th Annual International Conference of the IEEE. IEEE, 2013.
[6] Hirata, Masayuki, et al. "A fully-implantable wireless system for human brain-machine 
interfaces using brain surface electrodes: W-HERBS." IEICE transactions on 
communications 94.9 (2011): 2448-2453.
[7] Anderson, Grant S., and Reid R. Harrison. "Wireless integrated circuit for the acquisition 
of electrocorticogram signals." Circuits and Systems (ISCAS), Proceedings of 2010 IEEE 
International Symposium on. IEEE, 2010.
[8] Chang, Chih-Wei, and Jin-Chern Chiou. "A wireless and batteryless microsystem with 
implantable grid electrode/3-dimensional probe array for ECoG and extracellular neural 
recording in rats." Sensors 13.4 (2013): 4624-4639.
[9] Wang, Po T., et al. "A co-registration approach for electrocorticogram electrode 
localization using post-implantation MRI and CT of the head." Neural Engineering (NER), 
2013 6th International IEEE/EMBS Conference on. IEEE, 2013.
[10] Charvet, G., et al. "A wireless 64-channel ECoG recording electronic for implantable 
monitoring and BCI applications: WIMAGINE." Engineering in Medicine and Biology 
Society (EMBC), 2012 Annual International Conference of the IEEE. IEEE, 2012.
85
[11] Speck, Verena, et al. "Lumbar catheter for monitoring of intracranial pressure in patients 
with post-hemorrhagic communicating hydrocephalus." Neurocritical care 14.2 (2011): 208-
215.
[12] N. KAPADIA, AN JHA, F. "Simultaneous lumbar and intraventricular manometry to 
evaluate the role and safety of lumbar puncture in raised intracranial pressure following 
subarachnoid haemorrhage." British journal of neurosurgery 10.6 (1996): 585-588. 
[13] Lenfeldt, Niklas, et al. "CSF pressure assessed by lumbar puncture agrees with
intracranial pressure." Neurology 68.2 (2007): 155-158.
[14] Smith, Martin. "Monitoring intracranial pressure in traumatic brain injury."Anesthesia 
& Analgesia 106.1 (2008): 240-248.
[15] Zhong, Jun, et al. "Advances in ICP monitoring techniques." Neurological research 25.4 
(2003): 339-350.
[16] March, Karen. "Intracranial pressure monitoring: why monitor?." AACN Advanced 
Critical Care 16.4 (2005): 456-475.
[17] Steiner, L. A., and P. J. D. Andrews. "Monitoring the injured brain: ICP and 
CBF." British journal of anaesthesia 97.1 (2006): 26-38.
[18] Bhatia, Anuj, and Arun Kumar Gupta. "Neuromonitoring in the intensive care unit. I. 
Intracranial pressure and cerebral blood flow monitoring." Intensive care medicine 33.7 
(2007): 1263-1271.
[19] Binz, Daniel D., L. Gerard Toussaint III, and Jonathan A. Friedman. "Hemorrhagic 
complications of ventriculostomy placement: a meta-analysis."Neurocritical care 10.2 
(2009): 253-256.
[20] Beer, R., et al. "Nosocomial ventriculitis and meningitis in neurocritical care 
patients." Journal of neurology 255.11 (2008): 1617-1624.
[21] Hoefnagel, D., et al. "Risk factors for infections related to external ventricular 
drainage." Acta neurochirurgica 150.3 (2008): 209-214. 
86
[22] Brain, Trauma Foundation. "Guidelines for the management of severe traumatic brain 
injury. IV. Infection prophylaxis." Journal of neurotrauma 24 (2007): S26.
[23] Lozier, Alan P., et al. "Ventriculostomy-related infections: a critical review of the 
literature." Neurosurgery 51.1 (2002): 170-182
[24] Fichtner, Jens, et al. "Efficacy of silver-bearing external ventricular drainage catheters: a 
retrospective analysis: Clinical article." Journal of neurosurgery112.4 (2010): 840-846.
[25] O'Neill, Brent R., et al. "A survey of ventriculostomy and intracranial pressure monitor 
placement practices." Surgical neurology 70.3 (2008): 268-273.
[26] O'Leary, Shaun T., et al. "Efficacy of the Ghajar Guide revisited: a prospective 
study." Journal of neurosurgery 92.5 (2000): 801-803.
[27] Drake, J. M. "Ventriculostomy for treatment of hydrocephalus." Neurosurgery Clinics of 
North America 4.4 (1993): 657-666. 
[28] North, Brian, and Peter Reilly. "Comparison among three methods of intracranial 
pressure recording." Neurosurgery 18.6 (1986): 730-732.
[29] Bruder, N., et al. "A comparison of extradural and intraparenchymatous intracranial 
pressures in head injured patients." Intensive care medicine 21.10 (1995): 850-852.
[30] Eide, Per Kristian. "Comparison of simultaneous continuous intracranial pressure (ICP) 
signals from ICP sensors placed within the brain parenchyma and the epidural 
space." Medical engineering & physics 30.1 (2008): 34-40.
[31] Weinstabl, Christian, et al. "Comparative analysis between epidural (Gaeltec) and 
suboural (Camino) intracranial pressure probes." Journal of clinical monitoring 8.2 (1992): 
116-120.
[32] Poca, Maria Antonia, et al. "Is intracranial pressure monitoring in the epidural space 
reliable? Fact and fiction." Journal of neurosurgery 106.4 (2007): 548-556.
[33] Gelabert-Gonzalez, M., et al. "The Camino intracranial pressure device in clinical 
practice. Assessment in a 1000 cases." Acta neurochirurgica 148.4 (2006): 435-441.
87
[34] Bekar, A., et al. "Risk factors and complications of intracranial pressure monitoring with 
a fiberoptic device." Journal of Clinical Neuroscience 16.2 (2009): 236-240.
[35] Hong, Wei-Chen, et al. "Subdural intracranial pressure monitoring in severe head injury: 
clinical experience with the Codman MicroSensor." Surgical neurology 66 (2006): S8-S13.
[36] Koskinen, Lars-Owe D., and Magnus Olivecrona. "Clinical experience with the 
intraparenchymal intracranial pressure monitoring Codman MicroSensor 
system." Neurosurgery 56.4 (2005): 693-698.
[37] Citerio, Giuseppe, et al. "Multicenter Clinical Assessment of the Raumedic Neurovent‐P 
Intracranial Pressure Sensor: A Report By the Brainit Group."Neurosurgery 63.6 (2008): 
1152-1158.
[38] Lescot, Thomas, et al. "In vivo accuracy of two intraparenchymal intracranial pressure 
monitors." Applied Physiology in Intensive Care Medicine 1. Springer Berlin Heidelberg, 
2012. 249-253.
[39] Allin, David, Marek Czosnyka, and Zofia Czosnyka. "Laboratory testing of the Pressio 
intracranial pressure monitor." Neurosurgery 62.5 (2008): 1158-1161
[40] Lang, Josef-Michael, et al. "Clinical evaluation of intraparenchymal Spiegelberg 
pressure sensor." Neurosurgery 52.6 (2003): 1455-1459.
[41] Kiening, K. L., et al. "Continuous monitoring of intracranial compliance after severe 
head injury: relation to data quality, intracranial pressure and brain tissue PO2." British 
journal of neurosurgery 17.4 (2003): 311-318.
[42] Kiening, K. L., et al. "Assessment of the relationship between age and continuous 
intracranial compliance." Intracranial Pressure and Brain Monitoring XII. Springer Vienna, 
2005. 293-297.
[43] Shellock, Frank G. "Biomedical implants and devices: Assessment of magnetic field 
interactions with a 3.0‐Tesla MR system." Journal of Magnetic Resonance Imaging 16.6 
(2002): 721-732.
88
[44] Stendel, R., et al. "Clinical evaluation of a new intracranial pressure monitoring 
device." Acta neurochirurgica 145.3 (2003): 185-193.
[45] Bellner, Johan, et al. "Transcranial Doppler sonography pulsatility index (PI) reflects 
intracranial pressure (ICP)." Surgical neurology 62.1 (2004): 45-51.
[46] Moreno, José A., et al. "Evaluating the outcome of severe head injury with transcranial 
Doppler ultrasonography." Neurosurgical focus 8.1 (2000): 1-7.
[47] Voulgaris, Spyridon G., et al. "Early cerebral monitoring using the transcranial Doppler 
pulsatility index in patients with severe brain trauma." Annals of Transplantation 11.2 
(2005): CR49-CR52.
[48] Behrens, Anders, et al. "Transcranial Doppler pulsatility index: not an accurate method 
to assess intracranial pressure." Neurosurgery 66.6 (2010): 1050-1057.
[49] Brandi, Giovanna, et al. "Transcranial color-coded duplex sonography allows to assess 
cerebral perfusion pressure noninvasively following severe traumatic brain injury." Acta 
neurochirurgica 152.6 (2010): 965-972.
[50] Reid, A., et al. "The relationship between intracranial pressure and tympanic membrane 
displacement." British journal of audiology 24.2 (1990): 123-129.
[51] Shimbles, S., et al. "Clinical comparison of tympanic membrane displacement with 
invasive intracranial pressure measurements." Physiological measurement26.6 (2005): 1085.
[52] Kimberly, Heidi Harbison, et al. "Correlation of optic nerve sheath diameter with direct 
measurement of intracranial pressure." Academic Emergency Medicine15.2 (2008): 201-204.
[53] Rajajee, Venkatakrishna, et al. "Optic nerve ultrasound for the detection of raised 
intracranial pressure." Neurocritical care 15.3 (2011): 506-515.
[54] Bäuerle, Jochen, et al. "Intra‐and Interobsever Reliability of Sonographic Assessment of 
the Optic Nerve Sheath Diameter in Healthy Adults." Journal of Neuroimaging 22.1 (2012): 
42-45.
89
[55] Marshall, I., et al. "Assessment of factors affecting MRI measurement of intracranial 
volume changes and elastance index." British journal of neurosurgery 22.3 (2008): 389-397.
[56] Dunn, Laurence T. "Raised intracranial pressure." Journal of Neurology, Neurosurgery 
& Psychiatry 73.suppl 1 (2002): i23-i27.
[57] Lemaire, J. J., et al. "Slow pressure waves in the cranial enclosure." Acta 
neurochirurgica 144.3 (2002): 243-254.
[58] Yaniger, S. I. "Force sensing resistors: A review of the technology." Electro 
International, 1991. IEEE, 1991.
[59] Hollinger, Avrum, and Marcelo M. Wanderley. "Evaluation of commercial force-sensing 
resistors." Proceedings of International Conference on New Interfaces for Musical 
Expression. 2006.
[60] Eventoff, Franklin N. "Pressure transducer." U.S. Patent No. 4,314,228. 2 Feb. 1982.
[61] Ferguson-Pell, Martin, Satsue Hagisawa, and Duncan Bain. "Evaluation of a sensor for 
low interface pressure applications." Medical engineering & physics22.9 (2000): 657-663
[62] Flórez, J. A., and A. Velasquez. "Calibration of force sensing resistors (fsr) for static and 
dynamic applications." ANDESCON, 2010 IEEE. 2010.
[63] Meng, Xu, et al. "Dynamic evaluation of a digital wireless intracranial pressure sensor 
for the assessment of traumatic brain injury in a swine model."Microwave Theory and 
Techniques, IEEE Transactions on 61.1 (2013): 316-325.
[64] "Camino Pressure Sensor Product Models" Integra Life. Web 
<http://www.integralife.com/products%2FPDFs%2FNeuroCriticalCare%2FCamino%20Broc
hure.pdf>
[65] "Codman ICP Monitoring System" DePuy Synthes. Web 
<https://emea.depuysynthes.com/hcp/codman-neuro/products/qs/icp-monitoring-system>
[66] " Intracranial Pressure Monitoring" Speigelberg. Web<http://www.spiegelberg.de/>
90
[67] " FSR 101 - The Basics" Sensitronics LLC. Web<http://sensitronics.com/fsr101.htm>
[68] "1620 MEMS Blood Pressure Sensor: Measurement Specialties. Web<http://www.meas-
spec.com/downloads/1620.pdf>
[69] "Membrane Switch Spacers" Solutions 3M. 
Web<http://multimedia.3m.com/mws/media/66424O/3mtm-200mp-membrane-switch.pdf>
[70] "Single Zone Sensors" Sensitronics LLC. Web <http://sensitronics.com/products-1-inch-
thru-mode-fsr.php>
[71] "Instrumentation Amplifier INA 101" Burr Brown. 
Web<http://pdf.datasheetcatalog.com/datasheet/BurrBrown/mXryuyt.pdf>
[72] Clasa Anesthesia. Web< http://www.clasa-
anestesia.org/revistas/argentina/HTML/ArgMonitoreo_Neurolgico.htm >
91
APPENDIX A
IACUC PROTOCOL APPROVAL AND AMMENDEMENT
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Institutional Animal Care and Use Committee (IACUC)
Office of Research Integrity and Assurance
Arizona State University_______________________________________________
660 South Mill 
Avenue, Suite 315 
Tempe, Arizona 
85287-6111
Phone: (480) 965-4387 FAX: (480) 965-7772
Animal Protocol Review
ASU Protocol Number: 15‐1420R
Protocol Title: Intracranial Pressure Monitoring
Principal Investigator: Jennifer Blain Christen
Date of Action: 2/26/2015
The animal protocol review was considered by the Committee and the following decisions were 
made:
The protocol was approved as modified.
If you have not already done so, documentation of Level III Training (i.e., procedure‐specific 
training) will need to be provided to the IACUC office before participants can perform 
procedures independently. For more information on Level III requirements see 
https://researchintegrity.asu.edu/training/animals/levelthree.
Total # of Animals: 5
Species: Rats
Pain Level:  
D
Protocol Approval Period: 2/26/2015 – 2/25/2018
Sponsor: N/A
ASU Proposal/Award #: N/A
Title: N/A
Signature: __ ______________________________________ Date: 3/4/2015
IACUC Chair or
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Institutional Animal Care and Use Committee (IACUC)
Office of Research Integrity and Assurance
Arizona State University_______________________________________________
660 South Mill 
Avenue, Suite 315 
Tempe, Arizona 
85287-6111
Phone: (480) 965-4387 FAX: (480) 965-7772
Animal Protocol Review
ASU Protocol Number: 15‐1420R Amendment #1
Protocol Title: Intracranial Pressure Monitoring
Principal Investigator: Jennifer Blain Christen
Date of Action: 3/6/2015
The animal protocol review was considered by the Committee and the following decisions were 
made:
The amendment was approved by Designated Review 
to allow for single housing and to change Dr. Jennifer 
Blain Christen’s role in the protocol.
If you have not already done so, documentation of Level III Training (i.e., procedure‐specific 
training) will need to be provided to the IACUC office before participants can perform 
procedures independently. For more information on Level III requirements see 
https://researchintegrity.asu.edu/training/animals/levelthree.
Total # of Animals: 5
Species: Rats
Pain Level:  
D
Protocol Approval Period: 2/26/2015 – 2/25/2018
Sponsor: N/A
ASU Proposal/Award #: N/A
Title: N/A
ignature: __ ______________________________________ Date: 3/6/2015
IACUC Chair or
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Institutional Animal Care and Use Committee (IACUC)
Office of Research Integrity and Assurance
Arizona State University_______________________________________________
660 South Mill 
Avenue, Suite 315 
Tempe, Arizona 
85287-6111
Phone: (480) 965-4387 FAX: (480) 965-7772
Animal Protocol Review
ASU Protocol Number: 15‐1420R Amendment #2
Protocol Title: Intracranial Pressure Monitoring
Principal Investigator: Jennifer Blain Christen
Date of Action: 3/9/2015
The animal protocol review was considered by the Committee and the following decisions were 
made:
The amendment was administratively approved to 
allow for the one time change in drugs used to 
decrease intracranial pressure.
If you have not already done so, documentation of Level III Training (i.e., procedure‐specific 
training) will need to be provided to the IACUC office before participants can perform 
procedures independently. For more information on Level III requirements see
https://researchintegrity.asu.edu/training/animals/levelthree.
Total # of Animals: 5
Species: Rats
Pain Level:  
D
Protocol Approval Period: 2/26/2015 – 2/25/2018
Sponsor: N/A
ASU Proposal/Award #: N/A
Title: N/A
Signature: __ ______________________________________ Date: 3/13/2015
IACUC Chair or
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APPENDIX B
PHOTOGRAPH OF PROTOTYPING, DEVELOPED SYSTEM, BENCH TESTING 
SET UP AND ANIMAL MODEL IMPLANTATION
96
Sensing cup dimensions:
97
Sensing cup sealed onto the sensor
Prototyped and packaged circuit
98
Bench Testing 
Static test experimental setup
Dynamic test experimental setup
99
Animal Model Implementation Test setup 
